HBV
ANTIGENIC PROPERTIES OF WILD-TYPE AND MUTANT HEPATITIS B VIRUS SURFACE ANTIGENS
(J.YOKOSAWA, T.ULANOVA, L.IOSHIMOTO, N.GRANOVSKI, C.MIYAKI, I.RAW, Y.KHUDYAKOV, H.FIELDS, 10th international Symposium on viral hepatitis and liver disease, Atlanta, April, 2000, Antiviral Therapy 2000,5 (Suppl.1):P.27)
(T.ULANOVA, J.YOKOSAWA, A.BURKOV, V.PUZYREV, A.OBRIADINA, 14th European Congress of Clinical Microbiology and Infectious Diseases.- Prague, 2004.-P.1075)
THE NEW HBsAg ELISA-KIT "DS-EIA-HBsAg-0.01" WITH THE INCREASED SENSITIVITY (23.5Kb)
(T.I.ULANOVA, S.N.IGOLKINA, N.I.EGOROVA, I.N.SHARIPOVA, V.R.PUZYREV, A.P.OBRIADINA, A.N.BURKOV, 12 th International Symposium on Viral Hepatitis and Liver Disease, Paris, 2006.)
EVALUATION ABILITY OF DS-EIA-HBsAg-0,01 ASSAY TO REDUCE SEROCONVERSION WINDOW PERIOD (23.5Kb)
(N.EGOROVA, I.PYRENKOVA, S.IGOLKINA, I.SHARIPOVA, V.PUZYREV, A.OBRIADINA, A.BURKOV, T.ULANOVA, XVII Regional Congress of the International Society of Blood Transfusion (ISBT), Europe, June 23-27, 2007, Madrid, Spain)
(N.I.EGOROVA, S.N.IGOLKINA, I.Y.PYRENKOVA, I.N.SHARIPOVA, V.F.PUZYREV, A.P.OBRIADINA, A.N.BURKOV, T.I.ULANOVA, 13lh International Symposium on Viral Hepatitis and Liver Disease, Washington, DC USA March 20-24, 2009)
(N.I.EGOROVA, S.N.IGOLKINA, I.Y.PYRENKOVA, I.N.SHARIPOVA, V.F.PUZYREV, A.P.OBRIADINA, A.N.BURKOV, T.I.ULANOVA, 21st European Congress of Clinical Microbiology and Infectious Diseases,- Italy, Milan,
7-10 May 2011)
(N.EGOROVA, S.IGOLKINA, I.PYRENKOVA, I.SHARIPOVA, V.PUZYREV, A.OBRIADINA, A.BURKOV, T.ULANOVA, 20th European Congress of Clinical Microbiology and Infectious Diseases.-Vienna.-Austria. 10-13 April 2010.-Р.1083)